Gallstone-related Pancreatitis Fuels Enzyme Market Growth

pancreatin market in 2021, driven by high consumer awareness about health supplements. Europe, with a market value of US$ 33.4 Mn in 2021, is a frontrunner, with Germany contributing 15.8% to the global market.

The global pancreatin market is poised for significant growth over the next decade, fueled by increasing awareness about the benefits of enzyme-based supplements, rising prevalence of pancreatic diseases, and expanding applications across industries. Valued at US$ 101.4 Mn in 2021, the market is expected to grow at a CAGR of 5.7% to reach US$ 175.7 Mn by 2031. This blog explores the trends, challenges, and opportunities shaping the pancreatin market.

Review our report to gain deeper insights and understanding - https://www.transparencymarketresearch.com/pancreatin-market.html

Key Players in the Pancreatin Market

Key players of Pancreatin Market are Biovencer Healthcare Private Limited, Nordmark, Fengchen Group Co., Ltd, Biozyme, Sichuan Biosyn Pharmaceutical Co., Ltd, Bioseutica, Wellona Pharma, Shreeji Pharma International, Hetero Healthcare Limited, Creative Enzymes, Baoding Faithful Industry Co. Ltd., SG Pharma Pvt. Ltd, Provita Nutrition and Health Inc, Hepalink Group, NOW® Foods, Bio Basic Inc., Sichuan Deebio Pharmaceutical Co., Ltd., Enzyme Bioscience Pvt. Ltd, Umang Pharmaceuticals, Antozyme Bio

Emerging Trends in the Pancreatin Market

  1. Science-backed Supplements and Health-conscious Consumers

Health-conscious consumers are driving demand for modern supplements that combine enzymes from animal, plant, and microbial sources. Science-backed solutions that benefit microbiome health are gaining traction. Companies are leveraging probiotic, prebiotic, and enzyme technologies to create innovative products. For instance, microbiomes serve as a significant source of enzymes for commercially produced supplements.

  1. Less-interrupted Supply Chains During COVID-19

The pandemic caused disruptions across industries, including pancreatin production. To mitigate these effects, companies adapted to new standard operating procedures (SOPs) and leveraged eCommerce platforms for product sales. Health-conscious consumers during the pandemic further fueled demand for enzyme-based health foods.

  1. R&D for Cost-effective Pancreatin Products

High production costs remain a challenge, but manufacturers are investing in R&D to develop cost-effective solutions. This includes diversification into applications like the leather industry, where pancreatin is used as an alternative to alkaline proteases for processing animal skin.

Regional Insights: Pancreatin Market

  1. Dominance of North America and Europe

North America and Europe accounted for over 57% of the global pancreatin market in 2021, driven by high consumer awareness about health supplements. Europe, with a market value of US$ 33.4 Mn in 2021, is a frontrunner, with Germany contributing 15.8% to the global market.

  1. Asia-Pacific: A Promising Market

The Asia-Pacific region is expected to witness significant growth, driven by rising disposable incomes, increasing awareness about digestive health, and expanding applications in pharmaceuticals and food industries.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453


mayur gunjal

1191 blog posts

Reacties